In the context of the crosstalk between tumor cells, stromal cells, and immune cells, the interplay between CD44 and SPP1 has been proposed to suppress CD8 + T-cell activation and foster tumor immune tolerance and evasion [31]. This evidence concerns the gene SPP1 and neoplasm.